Which CJC-1295 study amounts are known?

How did CJC-1295 amounts differ for people and mice?

<a id="doses-used"></a>

What amounts did people receive in studies?

People studies gave one shot of 30, 60 or 90 ug/kg ^[1][3]. The unit means millionths of a gram for every kilogram a person weighed. It was not one fixed amount for all people. These CJC-1295 figures describe research, not care.

A mouse study gave 2 ug at gaps of 24-72 hours ^[4]. Those mice lacked the body's normal growth message. A mouse test cannot identify a safe amount for you. CJC-1295 isn't approved for people anywhere.

Online CJC-1295 plans may list fixed amounts of 100-300 ug. Some posts put one name on two things: short-form no-DAC and the CJC-1295/ipamorelin mixture. Those numbers did not come from people studies comparing groups ^[1]. A round online figure isn't a tested care plan.

One people study compared 30 and 60 ug/kg. Higher amounts produced a larger rise in IGF-1, a growth-linked blood protein. Growth hormone rose 2- to 10-fold, meaning its start was multiplied by two to ten. IGF-1 rose 1.5- to 3-fold, from its start plus half to three times its start ^[1].

Timing also mattered in CJC-1295 mice. One 2 ug shot every 24 hours restored normal growth. A 48- or 72-hour gap worked less well ^[4]. A mouse result can't become your schedule.

Which CJC-1295 DAC amounts were studied?

<a id="dac-doses"></a>

Which CJC-1295 DAC amounts did people receive?

One DAC study gave 30 or 60 ug/kg by shot. IGF-1, a growth-linked blood protein, remained raised for 9-11 days ^[1]. DAC joins the drug to albumin, which helps explain that span. In mice, the time between shots also affected growth ^[4].

A second study gave 60 or 90 ug/kg once. Blood tests measured growth hormone and IGF-1 after one week ^[3]. These facts don't form a care plan. They cannot identify a safe amount for you.

How did researchers handle the study material?

<a id="routes"></a>

Where did the people studies place the shot?

The main studies gave the shot just beneath the skin ^[1]. Earlier tests put the short, unaltered chain into a vein. The stomach breaks down peptides, which are short protein chains ^[2]. These facts report the studies; they are not directions.

How was the dry study material handled?

<a id="reconstitution"></a>

The lab mixed the dry chain with germ-resistant water. Staff then kept the mixture cold ^[1][2]. Four altered spots slowed breakdown inside the body. DAC, a joining part, made the drug remain longer by binding albumin.

Those details only tell you what the lab did. They aren't steps for making a human shot. CJC-1295 has no approved form for people. A lab method cannot make home handling safe.

Was CJC-1295 with ipamorelin tested in people?

<a id="combination"></a>

Which comparison is missing for the two drugs?

Researchers have not compared the pair with no drug or either single drug in people ^[13]. Ipamorelin is a lab drug that acts like the body's hunger hormone. CJC-1295 follows the usual growth-message route; ipamorelin follows a separate route ^[13][14]. When both routes were used, more growth hormone was released, but better health was not shown.

A pig study measured ipamorelin in blood and the growth hormone that followed ^[14]. Tests of related drugs found a larger hormone release when both gland routes were used ^[13]. No tested amount, ratio, or health result exists for this exact pair. Online plans cannot fill that gap.